Fresh Day Meds review

Fresh Day Meds names its operator and medical group and gives clear NAD⁺ and enclomiphene plan totals. The $159 NAD⁺ and $149 enclomiphene monthly equivalents require a $477 or $447 three-month renewal; the one-month plans are $199. A portal request must be confirmed before a future renewal is stopped. Once clinical work has begun, a patient cancellation can incur $75 even without a prescription, while a successful renewal allocates $75 within its price. Those details matter as much as the advertised rate.

Fresh Day Meds, LLC is a Houston, Texas telehealth platform operating across weight loss, longevity, sexual wellness, hair health and testosterone support on a single account. Its longevity line carries an NAD⁺ 1000mg injection and MIC+B12; its testosterone-support line carries enclomiphene tablets; its weight line carries compounded semaglutide and tirzepatide. Clinical care is delivered through Telegra MD, named in its Terms as the medical group. It shows a LegitScript seal, publishes its headquarters address, advertises free expedited shipping, and states there is no separate membership fee on its plans.

An online assessment is reviewed through Telegra MD; a hold for the full plan is captured only after approval, and initial physician-declared medical ineligibility releases it without a consultation charge. The terms describe confirmed cancellation or indefinite pause through Billing Management or Tickets. Merely opening a ticket does not stop billing, and processed terms are not unwound. A $75 fee can apply when a patient cancels or refuses after documented clinical work starts; a successful renewal includes an allocated $75 rather than adding it. The site sends a seven-day renewal reminder. Its Care+ four-month weight-loss guarantee applies only when included before purchase for eligible first-time GLP-1 patients; continuing treatment, a baseline video and a timely final claim are required, and a three-month plan normally needs another paid renewal. It lists 49 states plus DC, excluding Arkansas, and the Houston headquarters is not a walk-in clinic. The pharmacy remains unnamed.

NAD⁺ injection cards list $199 for one month with one-month supply, or $159 monthly equivalent with $477 paid for a three-month supply; enclomiphene tablets are $199 for one month or $149 equivalent with $447 for three. GLP-1 one-month prices are $140 semaglutide and $179 tirzepatide; new-patient three-month totals are $299 and $420, while transfer totals are $385 and $469. GLP-1 one-month plans renew every 23 days and three-month plans every 83 days, which differs from calendar months. The selected NAD⁺ and enclomiphene renewal day and any product-specific lab charge need confirmation. Free shipping applies, with oral/topical delivery generally slower than injection delivery after fulfillment.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Fresh Day describes state-licensed 503A and 503B compounding facilities but names no pharmacy, and compounded sterile products are not reviewed by FDA for purity and potency the way approved drugs are. On the evidence, the NAD⁺ injection is the weaker of its two relevant products by a distance: there are no controlled human outcome trials for injected NAD⁺, and the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker, not a demonstrated clinical outcome. Enclomiphene deserves separating from its category label. Fresh Day files it under testosterone support, and it is not testosterone: it is a selective estrogen receptor modulator that raises endogenous testosterone by increasing LH and FSH, with a different side-effect and monitoring profile from exogenous testosterone and, importantly, without the suppression of sperm production that testosterone causes. Its product page notes that laboratory testing and monitoring may be required. Anyone arriving here expecting injectable testosterone, a gel or a pellet will not find one. On the GLP-1 side the platform is compounded-only, with no brand-name fallback. Individual results vary.